Uptake and Spending on Biosimilar Infliximab and Etanercept After New Start and Switching Policies in Canada: An Interrupted Time Series Analysis
出版年份 2023 全文链接
标题
Uptake and Spending on Biosimilar Infliximab and Etanercept After New Start and Switching Policies in Canada: An Interrupted Time Series Analysis
作者
关键词
-
出版物
ARTHRITIS CARE & RESEARCH
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2023-02-08
DOI
10.1002/acr.25099
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Uptake of biosimilar drugs in Canada: analysis of provincial policies and usage data
- (2022) Alison R. McClean et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Trends in Canadian prescription drug purchasing: 2001–2020
- (2022) Mark Hofmeister et al. Journal of Pharmaceutical Policy and Practice
- Socioeconomic Status and Medication Use in Rheumatoid Arthritis: A Scoping Review
- (2022) Oscar Russell et al. ARTHRITIS CARE & RESEARCH
- Physician, Practice, and Patient Characteristics Associated With Biosimilar Use in Medicare Recipients
- (2021) Emma Boswell Dean et al. JAMA Network Open
- Policies to Encourage the Use of Biosimilars in European Countries and Their Potential Impact on Pharmaceutical Expenditure
- (2021) Sabine Vogler et al. Frontiers in Pharmacology
- Failure to Launch: Biosimilar Sales Continue to Fall Flat in the United States
- (2020) Jinoos Yazdany Arthritis & Rheumatology
- Utilization and Treatment Costs of Tumor Necrosis Factor Inhibitors after the Introduction of Biosimilar Infliximab in the U.S
- (2020) Seoyoung C. Kim et al. Arthritis & Rheumatology
- Uptake of Infliximab Biosimilars Among the Medicare Population
- (2020) Alice J. Chen et al. JAMA Internal Medicine
- Use of interrupted time series methods in the evaluation of health system quality improvement interventions: a methodological systematic review
- (2020) Celestin Hategeka et al. BMJ Global Health
- Physician attitudes about non-medical switching to biosimilars: results from an online physician survey in the United States
- (2019) A. Teeple et al. CURRENT MEDICAL RESEARCH AND OPINION
- The Danish model for the quick and safe implementation of infliximab and etanercept biosimilars
- (2019) Thomas Bo Jensen et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Biosimilars: Concepts and controversies
- (2018) Reyes Gámez-Belmonte et al. PHARMACOLOGICAL RESEARCH
- Systematic review: efficacy and safety of switching patients between reference and biosimilar infliximab
- (2018) Brian G. Feagan et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- To switch or not to switch: results of a nationwide guideline of mandatory switching from originator to biosimilar etanercept. One-year treatment outcomes in 2061 patients with inflammatory arthritis from the DANBIO registry
- (2018) Bente Glintborg et al. ANNALS OF THE RHEUMATIC DISEASES
- Biosimilars: How Can Payers Get Long-Term Savings?
- (2016) Jorge Mestre-Ferrandiz et al. PHARMACOECONOMICS
- Influence of Patient Sex and Gender on Medication Use, Adherence, and Prescribing Alignment with Guidelines
- (2013) Marie Manteuffel et al. JOURNAL OF WOMENS HEALTH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started